We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCO icon
201
Ducommun
DCO
$2.98B
$240K 0.04%
+2,900
New +$193K
IRBT
202
DELISTED
iRobot
IRBT
$238K 0.04%
76,000
-19,500
-20% -$53.9K
MRK icon
203
Merck
MRK
$322B
$237K 0.04%
3,000
– –
ELV icon
204
Elevance Health
ELV
$84.7B
$233K 0.04%
600
– –
JNJ icon
205
Johnson & Johnson
JNJ
$626B
$229K 0.04%
1,500
– –
TIGO icon
206
Millicom
TIGO
$15.9B
$225K 0.03%
+6,000
New +$206K
AOUT icon
207
American Outdoor Brands
AOUT
$159M
$225K 0.03%
21,500
– –
MKSI icon
208
MKS Inc
MKSI
$19.9B
$221K 0.03%
+2,220
New +$180K
CNC icon
209
Centene
CNC
$32.1B
$217K 0.03%
4,000
– –
TXT icon
210
Textron
TXT
$15.2B
$217K 0.03%
+2,700
New +$195K
DIS icon
211
Walt Disney
DIS
$179B
$211K 0.03%
+1,700
New +$177K
VMC icon
212
Vulcan Materials
VMC
$37.3B
$209K 0.03%
+800
New +$206K
F icon
213
Ford
F
$55.7B
$195K 0.03%
18,000
– –
WHG icon
214
Westwood Holdings Group
WHG
$182M
$172K 0.03%
11,000
– –
ARLO icon
215
Arlo Technologies
ARLO
$1.59B
$170K 0.03%
10,000
– –
OCSAW
216
Oculis Holding AG Warrants
OCSAW
$159K 0.02%
18,601
-45
-0.2% -$318
WEN icon
217
Wendy's
WEN
$1.44B
$148K 0.02%
13,000
– –
AVTR icon
218
Avantor
AVTR
$9.31B
$148K 0.02%
10,993
– –
CAEP
219
DELISTED
Cantor Equity Partners III
CAEP
$146K 0.02%
+13,800
New +$145K
CVAC
220
DELISTED
CureVac
CVAC
$141K 0.02%
+26,050
New +$103K
VMEO
221
DELISTED
Vimeo
VMEO
$127K 0.02%
31,500
– –
JVSAR
222
DELISTED
JV SPAC Acquisition Corp. Right
JVSAR
$126K 0.02%
145,200
+62,800
+76% +$26.1K
NABL icon
223
N-able
NABL
$595M
$126K 0.02%
15,500
– –
XRX icon
224
Xerox
XRX
$423M
$116K 0.02%
22,000
-200
-0.9% -$976
RCEL icon
225
Avita Medical
RCEL
$254M
$106K 0.02%
+20,000
New +$145K
7 8
9
10 11

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.